368 related articles for article (PubMed ID: 16421593)
1. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer.
Kawakami K; Ruszkiewicz A; Bennett G; Moore J; Grieu F; Watanabe G; Iacopetta B
Br J Cancer; 2006 Feb; 94(4):593-8. PubMed ID: 16421593
[TBL] [Abstract][Full Text] [Related]
2. APC gene methylation is inversely correlated with features of the CpG island methylator phenotype in colorectal cancer.
Iacopetta B; Grieu F; Li W; Ruszkiewicz A; Caruso M; Moore J; Watanabe G; Kawakami K
Int J Cancer; 2006 Nov; 119(10):2272-8. PubMed ID: 16981189
[TBL] [Abstract][Full Text] [Related]
3. Methylation levels of LINE-1 repeats and CpG island loci are inversely related in normal colonic mucosa.
Iacopetta B; Grieu F; Phillips M; Ruszkiewicz A; Moore J; Minamoto T; Kawakami K
Cancer Sci; 2007 Sep; 98(9):1454-60. PubMed ID: 17640302
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.
de Vogel S; Wouters KA; Gottschalk RW; van Schooten FJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; Weijenberg MP; van Engeland M
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3086-96. PubMed ID: 19843671
[TBL] [Abstract][Full Text] [Related]
5. Clinical and prognosis value of the CIMP status combined with MLH1 or p16
Saadallah-Kallel A; Abdelmaksoud-Dammak R; Triki M; Charfi S; Khabir A; Sallemi-Boudawara T; Mokdad-Gargouri R
Med Oncol; 2017 Aug; 34(8):147. PubMed ID: 28730335
[TBL] [Abstract][Full Text] [Related]
6. CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci.
Kawasaki T; Ohnishi M; Nosho K; Suemoto Y; Kirkner GJ; Meyerhardt JA; Fuchs CS; Ogino S
Mod Pathol; 2008 Mar; 21(3):245-55. PubMed ID: 18204436
[TBL] [Abstract][Full Text] [Related]
7. Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias.
Konishi K; Shen L; Wang S; Meltzer SJ; Harpaz N; Issa JP
Gastroenterology; 2007 Apr; 132(4):1254-60. PubMed ID: 17408633
[TBL] [Abstract][Full Text] [Related]
8. The association between methylenetetrahydrofolate reductase polymorphism and promoter methylation in proximal colon cancer.
Oyama K; Kawakami K; Maeda K; Ishiguro K; Watanabe G
Anticancer Res; 2004; 24(2B):649-54. PubMed ID: 15161007
[TBL] [Abstract][Full Text] [Related]
9. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
[TBL] [Abstract][Full Text] [Related]
10. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
[TBL] [Abstract][Full Text] [Related]
11. Lower specific micronutrient intake in colorectal cancer patients with tumors presenting promoter hypermethylation in p16(INK4a), p4(ARF) and hMLH1.
Mas S; Lafuente MJ; Crescenti A; Trias M; Ballesta A; Molina R; Zheng S; Wiencke JK; Lafuente A
Anticancer Res; 2007; 27(2):1151-6. PubMed ID: 17465256
[TBL] [Abstract][Full Text] [Related]
12. The dynamic DNA methylation landscape of the
Savio AJ; Mrkonjic M; Lemire M; Gallinger S; Knight JA; Bapat B
Clin Epigenetics; 2017; 9():26. PubMed ID: 28293327
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas.
Kim JC; Choi JS; Roh SA; Cho DH; Kim TW; Kim YS
Ann Surg Oncol; 2010 Jul; 17(7):1767-76. PubMed ID: 20077021
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype.
Toyota M; Ahuja N; Suzuki H; Itoh F; Ohe-Toyota M; Imai K; Baylin SB; Issa JP
Cancer Res; 1999 Nov; 59(21):5438-42. PubMed ID: 10554013
[TBL] [Abstract][Full Text] [Related]
15. Accelerated age-related CpG island methylation in ulcerative colitis.
Issa JP; Ahuja N; Toyota M; Bronner MP; Brentnall TA
Cancer Res; 2001 May; 61(9):3573-7. PubMed ID: 11325821
[TBL] [Abstract][Full Text] [Related]
16. Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer.
Wong JJ; Hawkins NJ; Ward RL; Hitchins MP
Mod Pathol; 2011 Mar; 24(3):396-411. PubMed ID: 21102416
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
An C; Choi IS; Yao JC; Worah S; Xie K; Mansfield PF; Ajani JA; Rashid A; Hamilton SR; Wu TT
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):656-63. PubMed ID: 15701853
[TBL] [Abstract][Full Text] [Related]
18. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter.
Koinuma K; Kaneda R; Toyota M; Yamashita Y; Takada S; Choi YL; Wada T; Okada M; Konishi F; Nagai H; Mano H
Carcinogenesis; 2005 Dec; 26(12):2078-85. PubMed ID: 16033773
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation in patients with colorectal cancer--correlation with some clinical and morphological features and with local tumour invasion.
Mirchev MB; Kahl P; Friedrichs N; Kotzev IA; Buettner R
Folia Med (Plovdiv); 2010; 52(2):22-30. PubMed ID: 20836393
[TBL] [Abstract][Full Text] [Related]
20. DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer.
Nosho K; Shima K; Irahara N; Kure S; Baba Y; Kirkner GJ; Chen L; Gokhale S; Hazra A; Spiegelman D; Giovannucci EL; Jaenisch R; Fuchs CS; Ogino S
Clin Cancer Res; 2009 Jun; 15(11):3663-71. PubMed ID: 19470733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
